Accenture (ACN) CEO Julie Sweet reports 333 RSU grant, 148 shares F

Accenture plc (ACN) Chair and CEO Julie Spellman Sweet, who also serves as a director, reported changes in her Accenture share holdings.

Rhea-AI Filing Summary

Accenture plc (ACN) Chair and CEO Julie Spellman Sweet, who also serves as a director, reported changes in her Accenture share holdings. On 11/14/2025, she acquired 333 Class A ordinary shares at $0 per share, increasing her position through a grant of restricted share units (RSUs) made under anti-dilution provisions tied to Accenture’s payment of a cash dividend. On the same date, she had a disposition coded “F” of 148 Class A ordinary shares at $246.62 per share. After these transactions, she beneficially owned 8,941 Class A ordinary shares in direct ownership.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Sweet Julie Spellman

Role Chair and CEO

Type	Security	Shares	Price	Value
Grant/Award	Class A ordinary shares	333	$0.00	$0.00
Exercise Price or Tax Liability	Class A ordinary shares	148	$246.62	$36K

Holdings After Transaction: Class A ordinary shares — 8,941 shares (Direct)

Footnotes (1)

1. F1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

FAQ

What insider transaction did Accenture (ACN) report for Julie Spellman Sweet?

Accenture reported that Julie Spellman Sweet, its Chair and CEO and a director, filed a Form 4 disclosing changes in her Class A ordinary share holdings on 11/14/2025.

How many Accenture (ACN) shares did Julie Sweet acquire on 11/14/2025?

On 11/14/2025, Julie Sweet acquired 333 Class A ordinary shares at $0 per share through a grant of restricted share units (RSUs).

Why did Julie Sweet receive additional RSUs in Accenture (ACN)?

The 333 RSUs were granted under the anti-dilution provisions of previously granted RSU awards to reflect Accenture plc’s payment of a cash dividend.

What was the disposition coded "F" in Julie Sweet’s Accenture (ACN) Form 4?

The Form 4 shows a transaction coded "F" for a disposition of 148 Class A ordinary shares at a price of $246.62 per share on 11/14/2025.

How many Accenture (ACN) shares does Julie Sweet own after these transactions?

Following the reported transactions, Julie Sweet beneficially owned 8,941 Class A ordinary shares, held with direct (D) ownership.

What is Julie Sweet’s relationship to Accenture (ACN)?

Julie Sweet is reported as both a Director and an Officer of Accenture plc, serving as Chair and CEO.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/18/2025 - 04:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sweet Julie Spellman

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	11/14/2025		A		333(1)	A	$0	9,089	D
Class A ordinary shares	11/14/2025		F		148	D	$246.62	8,941	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Remarks:

	/s/ Danika Haueisen, Attorney-In-Fact for Julie Spellman Sweet	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.